James R. Meyers

Insider Reports History

Entity
Individual
Location
Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James R. Meyers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC Director Common Stock 74.6K $44.8K $0.60 Jun 4, 2024 Direct
Arbutus Biopharma Corp Director Stock Option (Right to Buy) 67K May 23, 2024 Direct
SANGAMO THERAPEUTICS, INC Director Stock Option (Right to Buy) 50K Jun 4, 2024 Direct
CytomX Therapeutics, Inc. Director Stock Option (Right to Buy) 38K May 15, 2024 Direct

Insider Reports Filed by James R. Meyers

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
ABUS Arbutus Biopharma Corp May 23, 2024 1 $0 4 May 24, 2024 Director
CTMX CytomX Therapeutics, Inc. May 15, 2024 1 $0 4 May 17, 2024 Director
CTMX CytomX Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
SGMO SANGAMO THERAPEUTICS, INC Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
ABUS Arbutus Biopharma Corp May 24, 2023 1 $0 4 May 26, 2023 Director
CTMX CytomX Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ABUS Arbutus Biopharma Corp May 25, 2022 1 $0 4 May 26, 2022 Director
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 2 $0 4 Mar 1, 2022 Director
CTMX CytomX Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
ABUS Arbutus Biopharma Corp Jun 3, 2021 1 $0 4 Jun 7, 2021 Director